Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
GL ›
GLYXYN
Trademark search for:
GLYXYN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-01-05 — Application filed
2021-01-08 — Application filed
2021-04-03 — Application filed
2021-07-14 — Assigned to examiner
2021-07-16 — Final disposition recorded
2021-07-16 — Final disposition recorded
2021-07-16 — Final disposition recorded
2022-01-18 — Office action issued
2022-01-18 — Correspondence received in law office
2022-01-18 — Teas/email correspondence entered
2022-01-19 — Approved for pub - principal register
2022-02-02 — Notification of notice of publication e-mailed
2022-02-22 — Published for opposition
2022-02-22 — Official gazette publication confirmation e-mailed
2022-03-22 — Extension of time to oppose received
2022-08-22 — Teas post publication amendment received
2022-09-01 — Extension of time to oppose process - terminated
2022-09-08 — Assigned to petition staff
2022-09-08 — Post publication amendment - entered
2022-10-18 — Noa e-mailed - sou required from applicant
2023-04-05 — Sou teas extension received
2023-04-05 — Sou extension 1 filed
2023-04-05 — Sou extension 1 granted
2023-04-07 — Notice of approval of extension request e-mailed
2023-04-17 — Teas change of owner address received
2023-04-17 — Teas change of correspondence received
2023-04-17 — Applicant/correspondence changes (non-responsive) entered
2023-09-12 — Sou teas extension received
2023-09-12 — Sou extension 2 filed
2023-09-12 — Sou extension 2 granted
2023-09-14 — Notice of approval of extension request e-mailed
2024-01-25 — Sou teas extension received
2024-01-25 — Sou extension 3 filed
2024-01-25 — Sou extension 3 granted
2024-01-27 — Notice of approval of extension request e-mailed
2024-05-01 — Assigned to examiner
2024-07-23 — Sou teas extension received
2024-07-23 — Sou extension 4 filed
2024-07-23 — Sou extension 4 granted
2024-07-24 — Notice of approval of extension request e-mailed
2025-03-09 — Sou extension 5 filed
2025-03-10 — Sou teas extension received
2025-07-07 — Case assigned to intent to use paralegal
2025-07-07 — Sou extension 5 granted
2025-07-07 — Notice of approval of extension request e-mailed
2025-11-24 — Application abandoned
2025-11-24 — Application abandoned
2025-11-24 — Final status recorded
Owner Information
Biohaven Therapeutics Ltd.
Biohaven Therapeutics Ltd.
Correspondent
Monica Riva Talley STERNE KESSLER GOLDSTEIN & FOX PLLC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
